CNS uptake of bortezomib is enhanced by P-glycoprotein inhibition: implications for spinal muscular atrophy

Neurobiology of Disease
Emily ForanBarrington G Burnett

Abstract

The development of therapeutics for neurological disorders is constrained by limited access to the central nervous system (CNS). ATP-binding cassette (ABC) transporters, particularly P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), are expressed on the luminal surface of capillaries in the CNS and transport drugs out of the endothelium back into the blood against the concentration gradient. Survival motor neuron (SMN) protein, which is deficient in spinal muscular atrophy (SMA), is a target of the ubiquitin proteasome system. Inhibiting the proteasome in a rodent model of SMA with bortezomib increases SMN protein levels in peripheral tissues but not the CNS, because bortezomib has poor CNS penetrance. We sought to determine if we could inhibit SMN degradation in the CNS of SMA mice with a combination of bortezomib and the ABC transporter inhibitor tariquidar. In cultured cells we show that bortezomib is a substrate of P-gp. Mass spectrometry analysis demonstrated that intraperitoneal co-administration of tariquidar increased the CNS penetrance of bortezomib, and reduced proteasome activity in the brain and spinal cord. This correlated with increased SMN protein levels and improved survival and motor function o...Continue Reading

References

Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·V V RaoD Piwnica-Worms
Mar 18, 2005·Human Molecular Genetics·Lauren E KernochanCharlotte J Sumner
Jul 31, 2007·Biochemical and Biophysical Research Communications·Holger RumpoldDominik Wolf
Mar 4, 2009·International Journal of Laboratory Hematology·S LüJ Wang
Sep 5, 2009·Acta Haematologica·Gabriele BudaMario Petrini
Oct 13, 2010·The Journal of Biological Chemistry·Michael ScreenAlexei F Kisselev
Nov 30, 2010·Journal of Pharmacological and Toxicological Methods·Robert W RobeySusan E Bates
Mar 3, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shirin Arastu-KapurChristopher J Kirk
Jun 16, 2011·Annals of Neurology·Viktor BartanuszMurat Digicaylioglu
Apr 6, 2012·Frontiers in Pharmacology·Norman R SaundersKatarzyna M Dziegielewska
Aug 30, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·William M Pardridge
Apr 26, 2013·Molecular Biology of the Cell·Deborah Y KwonBarrington G Burnett
Jul 9, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Martin BauerOliver Langer
Dec 17, 2014·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·William C KreislRobert B Innis
Jan 13, 2015·Annals of Clinical and Translational Neurology·Michael R JablonskiPiera Pasinelli
Feb 12, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Martin BauerOliver Langer

❮ Previous
Next ❯

Citations

Sep 15, 2017·International Journal of Cancer. Journal International Du Cancer·Bo TangYu Hu
Dec 8, 2019·Pharmaceutical Development and Technology·Mohammad MahmoudianParvin Zakeri-Milani
Dec 23, 2016·Neurology·Franziska ScheibeAndreas Meisel
Nov 25, 2016·JCI Insight·Mahlet B AberaBarrington G Burnett
May 16, 2018·Annals of Clinical and Translational Neurology·Yong-Won ShinKon Chu
Apr 16, 2020·Frontiers in Neurology·Marion T TurnbullWilliam D Freeman
Apr 18, 2019·International Journal of Clinical Oncology·Azusa HayanoRyuya Yamanaka
Nov 12, 2019·Cancer Biology & Therapy·Jonathan D StropeWilliam D Figg
Sep 14, 2018·Frontiers in Cell and Developmental Biology·Zhe WangMargot Zöller
Sep 22, 2020·Brain Communications·Petra HuehnchenMatthias Endres
Jun 5, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·Nazneen Pathan, Pravin Shende
Aug 3, 2021·Cell Reports Medicine·Helena ChaytowThomas H Gillingwater
Jun 14, 2018·ACS Applied Materials & Interfaces·Dianjun QiBin Duan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood-Brain Barrier Transport in Neurodegeneration

The blood brain barrier is important for regulating the movement of biomolecules in and out of the brain. For example, membrane transporters in the blood brain barrier can be essential for regulating drug movement and dysregulation of these processes may play a role in neurodegeneration. This feed follows the latest research on this topic.

Related Papers

NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics
Wolfgang Löscher, Heidrun Potschka
Expert Opinion on Drug Metabolism & Toxicology
Teruo Murakami, Mikihisa Takano
Psychopharmacology
Silke ConenJohannes G Ramaekers
© 2022 Meta ULC. All rights reserved